Showing results (91-100 of 147) with videos related to
Sort By:
Pageof 15
The New Zealand Medical Journal|September 28, 1988
The quality of performance of the fructosamine testJ Upton, M Lever, W A Sadler, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|July 6, 2007
The molecular aetiology of haemophilia A in a New Zealand patient groupA D Laurie, C R Sheen, V Hanrahan, et al.Annals of Clinical Biochemistry|October 23, 2008
Uncertainty of sweat chloride testing: does the right hand know what the left hand is doing?R J Mackay, C M Florkowski, P M George, et al.Annals of Clinical Biochemistry|April 26, 2007
Quartz renal calculi: were we being led up the garden path?C W Sies, J Cadwallader, C M Florkowski, et al.Thrombosis and Haemostasis|April 20, 2001
Hypofibrinogenemia due to novel 316 Asp --> Tyr substitution in the fibrinogen Bbeta chainS O Brennan, J M Wyatt, S May, et al.Annals of the New York Academy of Sciences|July 20, 2001
Genetic and immunological characterization of fibrinogen inclusion bodies in patients with hepatic fibrinogen storage and liver diseaseD Medicina, G Fabbretti, S O Brennan, et al.Chemico-Biological Interactions|July 27, 1999
Catalytic parameters for the hydrolysis of butyrylthiocholine by human serum butyrylcholinesterase variantsV Simeon-Rudolf, E Reiner, R T Evans, et al.Lancet (London, England)|December 22, 1984
A genetically engineered mutant of alpha 1-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung diseaseP M George, M C Vissers, J Travis, et al.Journal of Clinical Pathology|February 1, 1996
Comparison of histological and biochemical hepatic iron indexes in the diagnosis of genetic haemochromatosisP M George, C Conaghan, H B Angus, et al.Pathology|January 1, 1991
Functional antithrombin-III variant (41 Pro----Leu) identified by liquid secondary ion mass spectrometryS O Brennan, J Y Borg, G J Shaw, et al.Pageof 15